These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33450077)

  • 1. Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas.
    Lincoln V; Chao L; Woodley DT; Murrell D; Kim M; O'Toole EA; Ly A; Cogan J; Mosallaei D; Wysong A; Chen M
    Exp Dermatol; 2021 May; 30(5):698-704. PubMed ID: 33450077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
    Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
    Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma.
    Knuutila JS; Riihilä P; Nissinen L; Heiskanen L; Kallionpää RE; Pellinen T; Kähäri VM
    Int J Cancer; 2024 Sep; 155(6):1112-1127. PubMed ID: 38648387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study.
    Filoni A; Cicco G; Cazzato G; Bosco A; Lospalluti L; Tucci M; Cimmino A; Foti C; Marzullo A; Bonamonte D
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression landscape of cutaneous squamous cell carcinoma progression.
    Bencomo T; Lee CS
    Br J Dermatol; 2024 Oct; 191(5):760-774. PubMed ID: 38867481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
    Welponer T; Weber DD; Trattner L; Tockner B; Aminzadeh-Gohari S; Leb-Reichl V; Kaufmann A; Zauner R; Wimmer M; Wally V; Felder TK; Strunk D; Koller U; Bauer JW; Kofler B; Guttmann-Gruber C; Piñon Hofbauer J
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):112-123. PubMed ID: 37669776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
    Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.
    Rami A; Łaczmański Ł; Jacków-Nowicka J; Jacków J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
    Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
    Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
    Nissinen L; Farshchian M; Riihilä P; Kähäri VM
    Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa.
    Trefzer L; Hess ME; Scholten L; Technau-Hafsi K; Meiss F; Boerries M; Has C; Rafei-Shamsabadi D
    Acta Derm Venereol; 2023 Jun; 103():adv4870. PubMed ID: 37338146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
    Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
    Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma.
    Dayal JHS; Mason SM; Salas-Alanis JC; McGrath JA; Taylor RG; Mellerio JE; Blyth K; South AP; Inman GJ
    Br J Dermatol; 2021 Apr; 184(4):697-708. PubMed ID: 32726455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
    Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
    Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin
    Wei WF; Chen XJ; Liang LJ; Yu L; Wu XG; Zhou CF; Wang ZC; Fan LS; Hu Z; Liang L; Wang W
    Mol Oncol; 2021 Jan; 15(1):210-227. PubMed ID: 33124726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
    Zuo S; Li X; Bao W; Li S
    Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.